Brief report: Human infection due to recombinant vaccinia-rabies glycoprotein virus
Brief report: Human infection due to recombinant vaccinia-rabies glycoprotein virus
复制标题
DOI：
10.1056/nejmoa010560
复制
发表时间：
2001-08-23
影响因子：
158.5
通讯作者：
Hanlon, CA
中科院分区：
文献类型：
--
作者：
Rupprecht, CE;Blass, L;Hanlon, CA
Rabies is a fatal viral disease transmitted from animals to humans. It causes more than 35,000 human deaths per year.1Successful application of veterinary vaccines can eliminate canine rabies in an area, but control of rabies in free-ranging carnivores requires other strategies, such as oral vaccination.2Live viral vaccines containing modified live rabies or recombinant vaccinia–rabies glycoprotein virus, placed in a bait, are used for disease control in Europe and North America.2–5In the United States, more than 22 million doses of vaccinia–rabies glycoprotein vaccine were distributed from 1990 to 2000, mainly to control rabies in raccoons in the . . .
